Farther Finance Advisors’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Sell
265,640
-3,497
-1% -$11.9K 0.01% 912
2026
Q1
$458K Buy
269,137
+20,517
+8% +$44.5K ﹤0.01% 1461
2025
Q4
$584K Buy
248,620
+14,687
+6% +$40.1K 0.01% 1206
2025
Q3
$716K Buy
233,933
+13,908
+6% +$39.7K 0.01% 892
2025
Q2
$614K Buy
220,025
+57,979
+36% +$191K 0.01% 817
2025
Q1
$582K Buy
162,046
+161,896
+107,931% +$650K 0.01% 724
2024
Q4
$473 Hold
150
﹤0.01% 3451
2024
Q3
$423 Hold
150
﹤0.01% 3464
2024
Q2
$180 Hold
150
﹤0.01% 3514
2024
Q1
$115 Hold
150
﹤0.01% 3359
2023
Q4
$143 Hold
150
﹤0.01% 3268
2023
Q3
$162 Hold
150
﹤0.01% 2495
2023
Q2
$135 Hold
150
﹤0.01% 2407
2023
Q1
$127 Hold
150
﹤0.01% 2265
2022
Q4
$139 Buy
+150
New +$200 ﹤0.01% 2098

Other funds holding CLOV

Farther Finance Advisors's CLOV Position: Q2 2026 in Review

Farther Finance Advisors reduced its Clover Health Investments (CLOV) stake by 1.3% in Q2 2026, selling an estimated $11.9K and leaving 265,640 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #912.

Farther Finance Advisors first reported a position in CLOV in Q4 2022 and has held it in 15 quarters since. 11 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Farther Finance Advisors held 265,640 shares of Clover Health Investments worth $1.39M as of Q2 2026.
  • Farther Finance Advisors sold 3,497 Clover Health Investments shares in Q2 2026, an estimated $11.9K.
  • Clover Health Investments made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #912 holding.
  • Farther Finance Advisors first reported a position in Clover Health Investments in Q4 2022 and has held it in 15 quarters since.
  • 11 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.